Clinical characteristics and healthcare burden of neurofibromatosis type 1 in Saudi Arabia: a single centre experience
This study highlights the clinical and healthcare challenges of NF1 and PN in Saudi Arabia, emphasizing the need for a multidisciplinary approach that combines medical, psychological, and financial support. The limited access to Selumetinib represents a gap. Increasing treatment accessibility and financial support are key to improving the outcomes and QoL.
Authors
- Mohammed Al Balwi (ORCID: https://orcid.org/0000-0003-2910-0390)
- Mohammed Almuqbil (ORCID: https://orcid.org/0000-0002-6057-9603)
- Seena Thomas Kaithathara
- Maha Al Ammari
- Nada S. Al Dhayyan
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdulaziz Medical City (SA)
- King Abdullah International Medical Research Center (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Hereditary Cancer in Clinical Practice
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s13053-025-00325-8
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00